August 25, 2022 Global Excellence in Biomanufacturing fueled by 150 years of creating value sustainably
Rentschler Biopharma began its role as a Contract Development and Manufacturing Organization (CDMO) for biopharmaceuticals in 1997. Founded in 1872 as a pharmacy in Laupheim, Germany, our company transitioned to pharmaceutical manufacturing, then branched out into biotechnology, and ultimately channeled its expertise and experience into becoming a global CDMO. Our success over the past 150 years has been based on a strong foundation of creating value sustainably, and that has paved the way for further advancement and success. As a reliable partner and a passionate enabler, Rentschler Biopharma transforms innovative ideas into life-saving biopharmaceuticals. By connecting experts, experience, and expertise, we are mastering complex problems to achieve the best solutions.
Today, we are a globally leading, premium full-service company that understands the complexity of biopharmaceutical manufacturing. We leverage our long-standing expertise to create value sustainably, for clients and patients. That has been key to our company’s success. These are some of the insightful thoughts shared in an article by Christiane Bardroff, our Senior Vice President of Client Program Management and Senior Vice President of Clinical and Commercial Manufacturing, in an equally special 20th anniversary issue of BPI.
To read the article, please follow this link: https://bioprocessintl.com/sponsored-content/global-excellence-in-biomanufacturing-fueled-by-150-years-of-creating-value-sustainably/
Rentschler Biopharma SE
Dr. Latika Bhonsle-Deeng
Senior Director Corporate Communication